103 related articles for article (PubMed ID: 7762669)
1. Galactosylated proteins are recognized by the liver according to the surface density of galactose moieties.
Nishikawa M; Miyazaki C; Yamashita F; Takakura Y; Hashida M
Am J Physiol; 1995 May; 268(5 Pt 1):G849-56. PubMed ID: 7762669
[TBL] [Abstract][Full Text] [Related]
2. Liver uptake and hepato-biliary transfer of galactosylated proteins in rats are determined by the extent of galactosylation.
Staud F; Nishikawa M; Takakura Y; Hashida M
Biochim Biophys Acta; 1999 Apr; 1427(2):183-92. PubMed ID: 10216235
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetic analysis of hepatic uptake of galactosylated bovine serum albumin in a perfused rat liver.
Ogawara K; Nishikawa M; Takakura Y; Hashida M
J Control Release; 1998 Jan; 50(1-3):309-17. PubMed ID: 9685898
[TBL] [Abstract][Full Text] [Related]
4. Design for cell-specific targeting of proteins utilizing sugar-recognition mechanism: effect of molecular weight of proteins on targeting efficiency.
Nishikawa M; Hirabayashi H; Takakura Y; Hashida M
Pharm Res; 1995 Feb; 12(2):209-14. PubMed ID: 7784335
[TBL] [Abstract][Full Text] [Related]
5. Efficient scavenger receptor-mediated hepatic targeting of proteins by introduction of negative charges on the proteins by aconitylation: the influence of charge density and size of the proteins molecules.
Yamasaki Y; Hisazumi J; Yamaoka K; Takakura Y
Eur J Pharm Sci; 2003 Apr; 18(5):305-12. PubMed ID: 12694882
[TBL] [Abstract][Full Text] [Related]
6. Effect of galactose density on asialoglycoprotein receptor-mediated uptake of galactosylated liposomes.
Managit C; Kawakami S; Yamashita F; Hashida M
J Pharm Sci; 2005 Oct; 94(10):2266-75. PubMed ID: 16136555
[TBL] [Abstract][Full Text] [Related]
7. Site-specific delivery of oligonucleotides to hepatocytes after systemic administration.
Zhu L; Ye Z; Cheng K; Miller DD; Mahato RI
Bioconjug Chem; 2008 Jan; 19(1):290-8. PubMed ID: 17850109
[TBL] [Abstract][Full Text] [Related]
8. Demonstration of the receptor-mediated hepatic uptake of dextran in mice.
Nishikawa M; Yamashita F; Takakura Y; Hashida M; Sezaki H
J Pharm Pharmacol; 1992 May; 44(5):396-401. PubMed ID: 1279155
[TBL] [Abstract][Full Text] [Related]
9. Hepatic disposition characteristics of 111In-labeled lactosaminated bovine serum albumin in rats.
Nishida K; Eguchi Y; Takino T; Takakura Y; Hashida M; Sezaki H
Pharm Res; 1991 Oct; 8(10):1253-7. PubMed ID: 1796043
[TBL] [Abstract][Full Text] [Related]
10. Development and pharmacokinetics of galactosylated poly-L-glutamic acid as a biodegradable carrier for liver-specific drug delivery.
Hirabayashi H; Nishikawa M; Takakura Y; Hashida M
Pharm Res; 1996 Jun; 13(6):880-4. PubMed ID: 8792426
[TBL] [Abstract][Full Text] [Related]
11. Biodistribution characteristics of galactosylated emulsions and incorporated probucol for hepatocyte-selective targeting of lipophilic drugs in mice.
Ishida E; Managit C; Kawakami S; Nishikawa M; Yamashita F; Hashida M
Pharm Res; 2004 Jun; 21(6):932-9. PubMed ID: 15212156
[TBL] [Abstract][Full Text] [Related]
12. Targeted delivery and improved therapeutic potential of catalase by chemical modification: combination with superoxide dismutase derivatives.
Yabe Y; Nishikawa M; Tamada A; Takakura Y; Hashida M
J Pharmacol Exp Ther; 1999 May; 289(2):1176-84. PubMed ID: 10215702
[TBL] [Abstract][Full Text] [Related]
13. Targeted delivery of human recombinant superoxide dismutase by chemical modification with mono- and polysaccharide derivatives.
Fujita T; Nishikawa M; Tamaki C; Takakura Y; Hashida M; Sezaki H
J Pharmacol Exp Ther; 1992 Dec; 263(3):971-8. PubMed ID: 1469654
[TBL] [Abstract][Full Text] [Related]
14. Biodistribution characteristics of mannosylated, fucosylated, and galactosylated liposomes in mice.
Kawakami S; Wong J; Sato A; Hattori Y; Yamashita F; Hashida M
Biochim Biophys Acta; 2000 Dec; 1524(2-3):258-65. PubMed ID: 11113576
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetic analysis of lectin-dependent biodistribution of fucosylated bovine serum albumin: a possible carrier for Kupffer cells.
Opanasopit P; Nishikawa M; Yamashita F; Takakura Y; Hashida M
J Drug Target; 2001; 9(5):341-51. PubMed ID: 11770704
[TBL] [Abstract][Full Text] [Related]
16. Disposition of radioactivity after injection of liver-targeted proteins labeled with 111In or 125I. Effect of labeling on distribution and excretion of radioactivity in rats.
Staud F; Nishikawa M; Morimoto K; Takakura Y; Hashida M
J Pharm Sci; 1999 Jun; 88(6):577-85. PubMed ID: 10350492
[TBL] [Abstract][Full Text] [Related]
17. Cellular distribution of 111In-LDTPA galactose BSA in normal and asialoglycoprotein receptor-deficient mouse liver.
Deal KA; Cristel ME; Welch MJ
Nucl Med Biol; 1998 May; 25(4):379-85. PubMed ID: 9639300
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetic evaluation of mannosylated bovine serum albumin as a liver cell-specific carrier: quantitative comparison with other hepatotropic ligands.
Ogawara K; Hasegawa S; Nishikawa M; Takakura Y; Hashida M
J Drug Target; 1999; 6(5):349-60. PubMed ID: 10342383
[TBL] [Abstract][Full Text] [Related]
19. Uptake characteristics of galactosylated emulsion by HepG2 hepatoma cells.
Managit C; Kawakami S; Yamashita F; Hashida M
Int J Pharm; 2005 Sep; 301(1-2):255-61. PubMed ID: 16076536
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetic analysis of in vivo disposition of succinylated proteins targeted to liver nonparenchymal cells via scavenger receptors: importance of molecular size and negative charge density for in vivo recognition by receptors.
Yamasaki Y; Sumimoto K; Nishikawa M; Yamashita F; Yamaoka K; Hashida M; Takakura Y
J Pharmacol Exp Ther; 2002 May; 301(2):467-77. PubMed ID: 11961045
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
